Release of biologically active TGF-β from airway smooth muscle cells induces autocrine synthesis of collagen

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 280, Issue 5 25-5, 2001, Pages

  Coutts, Amanda ^a   Chen, Gang ^b   Stephens, Newman ^c   Hirst, Stuart ^d   Douglas, Deborah ^a,b   Eichholtz, Thomas ^e   Khalil, Nasreen ^a,b  

^a UNIVERSITY OF MANITOBA   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c UNIVERSITY OF MANITOBA   (Canada)

^d KING'S COLLEGE LONDON   (United Kingdom)

^e GLAXOSMITHKLINE   (United Kingdom)

Author keywords

Bovine; Fibrosis; Plasmin; Remodeling; Transforming growth factor latency binding protein 1

Indexed keywords

BINDING PROTEIN; COLLAGEN; PLASMIN; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA LATENCY BINDING PROTEIN 1; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; COLLAGEN SYNTHESIS; CONTROLLED STUDY; FIBROSIS; IMMUNOHISTOCHEMISTRY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN SECRETION; SMOOTH MUSCLE FIBER; TRACHEA MUSCLE;

EID: 0035031745     PISSN: 10400605     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajplung.2001.280.5.l999     Document Type: Article

References (39)

1. American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD). Am J Respir Crit Care Med 152: S77-S121, 1995.
2. Border WA and Noble NA. Targeting TGF-β for the treatment of disease. Nat Med 1: 1000-1001, 1995.
3. Brown B, Wakefield LM, Levinson AD, and Sporn MB. Physiochemical activation of recombinant latent transforming growth factor β 1, 2 and 3. Growth Factors 3: 35-43, 1990.
4. Bruijn JA, Roos A, deGeus B, and deHeer E. Transforming growth factor-β and the glomerular extracellular matrix in renal pathology. J Lab Clin Med 123: 34-47, 1994.
5. Carroll N, Carello S, Cooke C, and James A. Airway structure and inflammatory cells in fatal attacks of asthma. Eur Respir J 9: 709-715, 1996.
6. Ebina M, Takahashi T, Chiba T, and Motomiya M. Cellular hypertrophy and hyperplasia of airway smooth muscles underlying bronchial asthma: a 3-D morphometric study. Am Rev Respir Dis 148: 720-726, 1993.
7. Garrett B and Garrett SB. Cellular communication and the action of growth factors during wound healing. J Wound Care 6: 277-280, 1997.
8. Grainger DJ, Kemp PR, Liu AC, Lawn RM, and Metcalfe JC. Activation of transforming growth factor-β is inhibited in transgenic apolipoprotein(a) mice. Nature 370: 460-462, 1994.
9. Halayko AJ, Salari H, Ma X, and Stephens NL. Markers of airway smooth muscle cell phenotype. Am J Physiol Lung Cell Mol Physiol 270: L1040-L1051, 1996.
10. Harrison P and Cramer EM. Platelet alpha-granules. Blood Rev 1: 52-62, 1993.
11. Heiden M, Seitz R, and Egbrin R.. The role of inflammatory cells and their proteases in extravascular fibronolysis. Semin Thromb Hemost 22: 497-501, 1996.
12. Hershenson MB, Naureckas ET, and Li J. Mitogen-activated signaling in cultured airway smooth muscle cells. Can J Physiol Pharmacol 75: 898-910, 1997.
13. Hirst SJ. Airway smooth muscle culture: application to studies of airway wall remodeling and phenotype plasticity in asthma. Eur Respir J 9: 808-820, 1996.
14. Huber D, Phillip J, and Fontana A. Protease inhibitors interfere with transforming growth factor-β-dependent but not the transforming growth factor-β-independent pathway of tumour cell mediated in immunoexsuppression. J Immunol 148: 277-284, 1992.
15. Jeffery PK. Structural and inflammatory abnormalities in COPD: a comparison with asthma. Thorax 53: 129-136, 1998.
16. Khalil N, Bereznay O, Sporn M, and Greenberg AH. Macrophage production of transforming growth factor-β and fibroblast collagen synthesis in chronic pulmonary inflammation. J Exp Med 170: 727-737, 1989.
17. Khalil N, Corne S, Whitman C, and Yacyshyn H. Plasmin regulates the activation of cell associated latent TGF-β1 secreted by rat alveolar macrophages after in vivo bleomycin injury. Am J Respir Cell Mol Biol 15: 252-259, 1996.
18. Khalil N, O'Connor RN, Flanders KC, Shing W, and Whitman CI. Regulation of type II alveolar epithelial cell proliferation by TGF-β during bleomycin-induced lung injury in rats. Am J Physiol Lung Cell Mol Physiol 267: L498-L507, 1994.
19. Khalil N, O'Connor R, Flanders K, and Unruh H. TGF-β1 but not TGF-β2 and TGF-β3 are differentially present in epithelial cells of advanced pulmonary fibrosis: an immunhistochemical study. Am J Respir Cell Mol Biol 14: 131-138, 1996.
20. Khalil N, Parekh T, Yan Y, O'Connor R, Chung S, and Gold L. After bleomycin lung injury regenerating alveolar epithelium has decresed expression of transforming growth factor-β (TGF-β) receptors (Abstract). Am J Respir Crit Care Med 155: A829, 1997.
21. Khalil N, Whitman C, Danielpour D, and Greenberg AH. Regulation of alveolar macrophage TGF-β secretion by corticosteroids in bleomycin induced pulmonary inflammation in the rat. J Clin Invest 92: 1812-1818, 1993.
22. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680-685, 1970.
23. Lee D, Vaughan DE, Parikh SH, Grodzinsky AJ, Libby P, Lark MW, and Lee JT. Regulation of matrix metalloproteinases and plasminogen activator inhibitor-1-synthesis by plasminogen in cultured human vascular smooth muscle cells. Circ Res 78: 44-49, 1996.
24. Lijnen HR. Pathophysiology of the plasminogen/plasmin system. Int J Clin Lab Res 26: 1-6, 1996.
25. McCartney-Francis NL and Wahl SM. Transforming growth factor β: a matter of life and death. J Leukoc Biol 55: 401-409, 1994.
26. Minshall EM, Leung DYM, Martin RJ, Song YL, Cameron L, Ernst P, and Hamid Q. Eosinophil-associated TGF-β1 mRNA expression and airways fibrosis in bronchial asthma. Am J Respir Cell Mol Biol 17: 326-333, 1997.
27. Munger JS, Harpel JG, Gleizes PE, Mazzieri R, Nunes S, and Rifkin DB. Latent transforming growth factor-β: structural features and mechanisms of activation. Kidney Int 51: 1376-1382, 1997.
28. Redington AE, Madden J, Frew AJ, Djukanovic R, Roche WR, Holgate ST, and Howarth PH. Transforming growth factor-β1 in asthma: measurement in bronchoalveolar lavage fluid. Am J Respir Crit Care Med 156: 642-647, 1997.
29. Reidy MA, Irvin C, and Lindner D. Migration of arterial wall cells: expression of plasminogen activators and inhibitors in injured rat arteries. Circ Res 78: 405-414, 1996.
30. Reisenbichler H and Jirtle RL. BSA treatment of plasticware reduces TGF β binding. Biotechniques 17: 675-676, 1994.
31. Roche WR, Beasley R, Williams JH, and Holgate ST. Subepithelial fibrosis in the bronchi of asthmatics. Lancet 1: 520-524, 1989.
32. Shelhamer JH, Levine SJ, Wu T, Jacoby DB, Kaliner MA, and Rennard SI. Airway inflammation. Ann Intern Med 123: 288-304, 1995.
33. Sinha S, Nevett C, Shuttleworth A, and Kielty CM. Cellular and extracellular biology of the latent transforming growth factor-β binding proteins. Matrix Biol 17: 529-545, 1998.
34. Sperti G, van Leuwen RTJ, Quax PHA, Maseri A, and Kluft C. Cultured rat aortic vascular smooth muscle cells digest naturally produced extracellular matrix: involvement of plasminogen-dependent and plasminogen-independent pathways. Circ Res 71: 385-392, 1992.
35. Taipale J, Lohi J, Saarinen J, Kovanen PT, and Keski-Oja J. Human mast cell chymase and leukocyte elastase release latent transforming growth factor-β1 from the extracellular matrix of cultured human epithelial and endothelial cells. J Biol Chem 270: 4689-4696, 1995.
36. Taipale J, Miyazono K, Heldin C-H, and Keski-Oja J. Latent transforming growth factor-β1 associates to fibroblast extracellular matrix via latent TGF-β binding protein. J Cell Biol 124: 171-181, 1994.
37. Vignola AM, Chanez P, Chiappara G, Merendino A, Pace E, Rizzo A, laRocca AM, Bellia V, Bonsignore G, and Bousquet J. Transforming growth factor-β expression in mucosal biopsies in asthma and chronic bronchitis. Am J Respir Crit Care Med 156: 591-599, 1997.
38. Wahl SM, Hunt DA, Wakefield LM, McCartney-Francis NL, Wahl LM, Roberts AB, and Sporn MB. Transforming growth factor type beta induces monocyte chemotaxis and growth factor production. Proc Natl Acad Sci USA 84: 5788-5792, 1997.
39. Yehaulaeshet T, O'Connor R, Green-Johnson J, Mai S, Silverstein R, Murphy-Ullrich JE, and Khalil N. Activation of rat alveolar macrophage derived L-TGF-β1 by plasmin requires interaction with TSP-1 and the TSP-1 cell surface receptor, CD36. Am J Pathol 155: 841-851, 1999.